{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:41:56Z","timestamp":1776944516380,"version":"3.51.4"},"reference-count":213,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007423","name":"Duchenne Parent Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007423","name":"Duchenne Parent Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.phrs.2020.104917","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T17:42:30Z","timestamp":1590860550000},"page":"104917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks"],"prefix":"10.1016","volume":"158","author":[{"given":"Brigida","family":"Boccanegra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid E.C.","family":"Verhaart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ornella","family":"Cappellari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Vroom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9869","key":"10.1016\/j.phrs.2020.104917_bib0005","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0140-6736(12)61897-2","article-title":"Muscular dystrophies","volume":"381","author":"Mercuri","year":"2013","journal-title":"Lancet (London, England)"},{"issue":"6","key":"10.1016\/j.phrs.2020.104917_bib0010","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.phrs.2020.104917_bib0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0092-8674(88)90383-2","article-title":"The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein","volume":"53","author":"Koenig","year":"1988","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.phrs.2020.104917_bib0020","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1152\/physrev.00028.2001","article-title":"Function and genetics of dystrophin and dystrophin-related proteins in muscle","volume":"82","author":"Blake","year":"2002","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2020.104917_bib0025","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.phrs.2020.104917_bib0030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104917_bib0035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1474-4422(18)30026-7","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.nmd.2014.11.011","article-title":"European Medicines Agency review of ataluren for the treatment of ambulant patients aged 5 years and older with Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene","volume":"25","author":"Haas","year":"2015","journal-title":"Neuromuscular Disorders: NMD"},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/nat.2016.0657","article-title":"FDA approves eteplirsen for duchenne muscular dystrophy: the next chapter in the eteplirsen Saga","volume":"27","author":"Aartsma-Rus","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.phrs.2020.104917_bib0050","article-title":"Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy [published online ahead of print, 2020 Mar 5]","author":"Frank","year":"2020","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.phrs.2020.104917_bib0055","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41582-019-0203-3","article-title":"Therapeutic developments for Duchenne muscular dystrophy","volume":"15","author":"Verhaart","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"8","key":"10.1016\/j.phrs.2020.104917_bib0060","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S1474-4422(16)30035-7","article-title":"Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophy","volume":"15","author":"Straub","year":"2016","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.phrs.2020.104917_bib0065","doi-asserted-by":"crossref","DOI":"10.3390\/nu10060796","article-title":"Skeletal muscle metabolism in Duchenne and Becker muscular dystrophy-implications for therapies","volume":"10","author":"Heydemann","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2020.104917_bib0070","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/867273","article-title":"Evidence of insulin resistance and other metabolic alterations in boys with duchenne or becker muscular dystrophy","author":"Rodriguez-Cruz","year":"2015","journal-title":"Int. J. Endocrinol."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2020.104917_bib0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1006868130002","article-title":"Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse","volume":"183","author":"Kuznetsov","year":"1998","journal-title":"Mol. Cell. Biochem."},{"issue":"21","key":"10.1016\/j.phrs.2020.104917_bib0080","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/hmg\/ddu287","article-title":"Gene expression in mdx mouse muscle in relation to age and exercise: aberrant mechanical-metabolic coupling and implications for pre-clinical studies in Duchenne muscular dystrophy","volume":"23","author":"Camerino","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.phrs.2020.104917_bib0085","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jprot.2017.09.009","article-title":"Proteome analysis in dystrophic mdx mouse muscle reveals a drastic alteration of key metabolic and contractile proteins after chronic exercise and the potential modulation by anti-oxidant compounds","volume":"170","author":"Gamberi","year":"2018","journal-title":"J. Proteomics"},{"issue":"12","key":"10.1016\/j.phrs.2020.104917_bib0090","doi-asserted-by":"crossref","first-page":"e115763","DOI":"10.1371\/journal.pone.0115763","article-title":"Defects in mitochondrial ATP synthesis in dystrophin-deficient mdx skeletal muscles may be caused by complex I insufficiency","volume":"9","author":"Rybalka","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.phrs.2020.104917_bib0095","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3148\/69.4.2008.208","article-title":"Body composition and resting energy expenditure of individuals with Duchenne and Becker muscular dystrophy","volume":"69","author":"Hogan","year":"2008","journal-title":"Can. J. Diet. Pract. Res."},{"issue":"2","key":"10.1016\/j.phrs.2020.104917_bib0100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.dsx.2017.08.006","article-title":"Energy expenditure, body composition, and prevalence of metabolic disorders in patients with Duchenne muscular dystrophy","volume":"12","author":"Saure","year":"2018","journal-title":"Diabetes Metab. Syndr."},{"issue":"3","key":"10.1016\/j.phrs.2020.104917_bib0105","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.braindev.2011.05.005","article-title":"Decreased resting energy expenditure in patients with Duchenne muscular dystrophy","volume":"34","author":"Shimizu-Fujiwara","year":"2012","journal-title":"Brain Dev-Jpn."},{"issue":"10","key":"10.1016\/j.phrs.2020.104917_bib0110","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1017\/S0007114510005180","article-title":"Natural evolution of weight status in Duchenne muscular dystrophy: a retrospective audit","volume":"105","author":"Martigne","year":"2011","journal-title":"Br. J. Nutr."},{"issue":"6","key":"10.1016\/j.phrs.2020.104917_bib0115","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.jpeds.2013.08.004","article-title":"Patterns of growth in ambulatory males with Duchenne muscular dystrophy","volume":"163","author":"West","year":"2013","journal-title":"J Pediatr-Us."},{"issue":"3","key":"10.1016\/j.phrs.2020.104917_bib0120","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/mus.26340","article-title":"Body composition and body mass index in Duchenne muscular dystrophy: role of dietary intake","volume":"59","author":"Bernabe-Garcia","year":"2019","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.phrs.2020.104917_bib0125","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/ejcn.2014.93","article-title":"Observations of body mass index in Duchenne muscular dystrophy: a longitudinal study","volume":"68","author":"Davidson","year":"2014","journal-title":"Eur. J. Clin. Nutr."},{"issue":"5","key":"10.1016\/j.phrs.2020.104917_bib0130","article-title":"Corticosteroids for the treatment of Duchenne muscular dystrophy","author":"Matthews","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5\u20136","key":"10.1016\/j.phrs.2020.104917_bib0135","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejpn.2006.08.008","article-title":"Feeding problems and weight gain in Duchenne muscular dystrophy","volume":"10","author":"Pane","year":"2006","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"8","key":"10.1016\/j.phrs.2020.104917_bib0140","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.nmd.2018.05.004","article-title":"Nutrition in Duchenne muscular dystrophy 16-18 March 2018, Zaandam, the Netherlands","volume":"28","author":"Verhaart","year":"2018","journal-title":"Neuromuscular Disorders: NMD"},{"issue":"6","key":"10.1016\/j.phrs.2020.104917_bib0145","doi-asserted-by":"crossref","DOI":"10.3390\/nu9060594","article-title":"Nutritional challenges in Duchenne muscular dystrophy","volume":"9","author":"Salera","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2020.104917_bib0150","series-title":"Dietary Reference Intakes for Calcium and Vitamin D","article-title":"Calcium. The national academies collection: reports funded by national institutes of health","author":"Institute of Medicine Committee to Review Dietary Reference Intakes for Vitamin D","year":"2011"},{"issue":"14","key":"10.1016\/j.phrs.2020.104917_bib0155","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2217\/cer-2019-0086","article-title":"Ataluren use in patients with nonsense mutation Duchenne muscular dystrophy: patient demographics and characteristics from the STRIDE Registry","volume":"8","author":"Muntoni","year":"2019","journal-title":"J. Comp. Eff. Res."},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0160","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1586\/17512433.2015.992878","article-title":"Using real-world healthcare data for pharmacovigilance signal detection - the experience of the EU-ADR project","volume":"8","author":"Patadia","year":"2015","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2020.104917_bib0165","first-page":"1","article-title":"Regulation (EU) no 1235\/2010 of the European Parliament and of the Council","volume":"348","author":"The European Parliament and the Council of the European Union","year":"2010","journal-title":"Off. J. Eur. Union"},{"key":"10.1016\/j.phrs.2020.104917_bib0170","first-page":"38","article-title":"Regulation (EU) no 1027\/2012 of the European Parliament and of the Council","volume":"316","author":"The European Parliament and the Council of the European Union","year":"2012","journal-title":"Off. J. Eur. Union"},{"issue":"7","key":"10.1016\/j.phrs.2020.104917_bib0175","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/17460441.1.7.737","article-title":"Development of an ADME and drug-drug interactions knowledge database for the acceleration of drug discovery and development","volume":"1","author":"Petitet","year":"2006","journal-title":"Expert Opin. Drug Discov."},{"issue":"18","key":"10.1016\/j.phrs.2020.104917_bib0180","doi-asserted-by":"crossref","first-page":"E4304","DOI":"10.1073\/pnas.1803294115","article-title":"Deep learning improves prediction of drug-drug and drug-food interactions","volume":"115","author":"Ryu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0185","doi-asserted-by":"crossref","DOI":"10.3390\/nu10010041","article-title":"Dietary supplements: regulatory challenges and research resources","volume":"10","author":"Dwyer","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2020.104917_bib0190","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1146\/annurev-pharmtox-010617-052844","article-title":"Adverse effects of nutraceuticals and dietary supplements","volume":"58","author":"Ronis","year":"2018","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.phrs.2020.104917_bib0195","series-title":"FDA Regulation of Drugs Versus Dietary Supplements","author":"American Cancer Society","year":"2015"},{"key":"10.1016\/j.phrs.2020.104917_bib0200","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/978-1-4939-7899-1_18","article-title":"Toxicity potential of nutraceuticals","volume":"1800","author":"Gupta","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.phrs.2020.104917_bib0205","first-page":"51","article-title":"Directive 2002\/46\/EC of the European parliament and of the council","volume":"183","author":"The European Parliament and the Council of the European Union","year":"2002","journal-title":"Off. J. Eur. Union"},{"issue":"6","key":"10.1016\/j.phrs.2020.104917_bib0210","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/0883073811426501","article-title":"Use of complementary and alternative medicine by males with Duchenne or Becker muscular dystrophy","volume":"27","author":"Nabukera","year":"2012","journal-title":"J. Child Neurol."},{"issue":"10","key":"10.1016\/j.phrs.2020.104917_bib0215","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/01.phm.0000233183.17059.b9","article-title":"The use of complementary and alternative medicine in children with chronic medical conditions","volume":"85","author":"Samdup","year":"2006","journal-title":"Am. J. Phys. Med. Rehabil."},{"issue":"11","key":"10.1016\/j.phrs.2020.104917_bib0220","doi-asserted-by":"crossref","DOI":"10.3390\/nu8110713","article-title":"Nutraceuticals and their potential to treat duchenne muscular dystrophy: separating the credible from the conjecture","volume":"8","author":"Woodman","year":"2016","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0225","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3233\/JND-170288","article-title":"Update on standard operating procedures in preclinical research for DMD and SMA report of TREAT-NMD Alliance Workshop, Schiphol Airport, 26 April 2015, The Netherlands","volume":"5","author":"van Putten","year":"2018","journal-title":"J. Neuromuscul. Dis."},{"issue":"4","key":"10.1016\/j.phrs.2020.104917_bib0230","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.nmd.2008.11.015","article-title":"Mammalian animal models for Duchenne muscular dystrophy","volume":"19","author":"Willmann","year":"2009","journal-title":"Neuromuscular disorders: NMD"},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2020.104917_bib0235","doi-asserted-by":"crossref","first-page":"269S","DOI":"10.1093\/jn\/136.1.269S","article-title":"Branched-chain amino acids activate key enzymes in protein synthesis after physical exercise","volume":"136","author":"Blomstrand","year":"2006","journal-title":"J. Nutr."},{"issue":"11","key":"10.1016\/j.phrs.2020.104917_bib0240","doi-asserted-by":"crossref","first-page":"C874","DOI":"10.1152\/ajpcell.00374.2015","article-title":"Activation of mTORC1 by leucine is potentiated by branched-chain amino acids and even more so by essential amino acids following resistance exercise","volume":"310","author":"Moberg","year":"2016","journal-title":"Am. J. Physiol., Cell Physiol."},{"key":"10.1016\/j.phrs.2020.104917_bib0245","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12970-017-0184-9","article-title":"Branched-chain amino acids and muscle protein synthesis in humans: myth or reality?","volume":"14","author":"Wolfe","year":"2017","journal-title":"J. Int. Soc. Sports Nutr."},{"issue":"3","key":"10.1016\/j.phrs.2020.104917_bib0250","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/mus.880050304","article-title":"Branched-chain ketoacids reduce muscle protein degradation in Duchenne muscular dystrophy","volume":"5","author":"Stewart","year":"1982","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1016\/j.phrs.2020.104917_bib0255","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/mus.880070704","article-title":"Clinical investigation in Duchenne muscular dystrophy: IV. Double-blind controlled trial of leucine","volume":"7","author":"Mendell","year":"1984","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.phrs.2020.104917_bib0260","doi-asserted-by":"crossref","first-page":"e1700756","DOI":"10.1002\/mnfr.201700756","article-title":"BCAA metabolism and insulin sensitivity - dysregulated by metabolic status?","volume":"62","author":"Gannon","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"issue":"9","key":"10.1016\/j.phrs.2020.104917_bib0265","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1093\/jn\/135.9.2103","article-title":"Isoleucine, a blood glucose-lowering amino acid, increases glucose uptake in rat skeletal muscle in the absence of increases in AMP-activated protein kinase activity","volume":"135","author":"Doi","year":"2005","journal-title":"J. Nutr."},{"issue":"12","key":"10.1016\/j.phrs.2020.104917_bib0270","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7120513","article-title":"Plasma branched-chain amino acids and risk of incident type 2 diabetes: results from the PREVEND prospective cohort study","volume":"7","author":"Flores-Guerrero","year":"2018","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0275","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.expneurol.2010.08.033","article-title":"Increased levels of p70S6 phosphorylation in the G93A mouse model of Amyotrophic Lateral Sclerosis and in valine-exposed cortical neurons in culture","volume":"226","author":"Carunchio","year":"2010","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0280","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.expneurol.2010.12.007","article-title":"Stronger is not always better: could a bodybuilding dietary supplement lead to ALS?","volume":"228","author":"Manuel","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2020.104917_bib0285","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12986-018-0271-1","article-title":"Branched-chain amino acids in health and disease: metabolism, alterations in blood plasma, and as supplements","volume":"15","author":"Holecek","year":"2018","journal-title":"Nutr Metab (Lond)."},{"issue":"2","key":"10.1016\/j.phrs.2020.104917_bib0290","doi-asserted-by":"crossref","first-page":"3","DOI":"10.17159\/2078-516X\/2004\/v16i2a180","article-title":"Inadvertent doping through nutritional supplements is a reality","volume":"16","author":"Van der Merwe","year":"2004","journal-title":"South Afr. J. Sport. Med."},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.csm.2007.09.003","article-title":"Supplements and the endocrine system in athletes","volume":"27","author":"Di Luigi","year":"2008","journal-title":"Clin. Sports Med."},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0300","doi-asserted-by":"crossref","first-page":"e0147634","DOI":"10.1371\/journal.pone.0147634","article-title":"Improved muscle function in duchenne muscular dystrophy through L-arginine and metformin: an investigator-initiated, open-label, single-center, proof-of-concept-study","volume":"11","author":"Hafner","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.phrs.2020.104917_bib0305","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00726-018-2614-7","article-title":"Effects of single and combined metformin and L-citrulline supplementation on L-arginine-related pathways in Becker muscular dystrophy patients: possible biochemical and clinical implications","volume":"50","author":"Hanff","year":"2018","journal-title":"Amino Acids"},{"issue":"6","key":"10.1016\/j.phrs.2020.104917_bib0310","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1006\/nbdi.1999.0256","article-title":"Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy","volume":"6","author":"Chaubourt","year":"1999","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0315","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.nbd.2005.02.010","article-title":"L-arginine improves dystrophic phenotype in mdx mice","volume":"20","author":"Voisin","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2020.104917_bib0320","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bcp.2018.04.022","article-title":"Effect of a long-term treatment with metformin in dystrophic mdx mice: a reconsideration of its potential clinical interest in Duchenne muscular dystrophy","volume":"154","author":"Mantuano","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2020.104917_bib0325","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/11538590-000000000-00000","article-title":"L-Arginine as a potential ergogenic aid in healthy subjects","volume":"41","author":"Alvares","year":"2011","journal-title":"Sports Med. (Auckland, NZ)"},{"issue":"7","key":"10.1016\/j.phrs.2020.104917_bib0330","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.3945\/jn.115.227959","article-title":"L-arginine supplementation alleviates postprandial endothelial dysfunction when baseline fasting plasma arginine concentration is low: a randomized controlled trial in healthy overweight adults with cardiometabolic risk factors","volume":"146","author":"Deveaux","year":"2016","journal-title":"J. Nutr."},{"issue":"3","key":"10.1016\/j.phrs.2020.104917_bib0335","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.yrtph.2008.01.004","article-title":"Risk assessment for the amino acids taurine, L-glutamine and L-arginine","volume":"50","author":"Shao","year":"2008","journal-title":"Regul. Toxicol. Pharmacol.: RTP"},{"issue":"12","key":"10.1016\/j.phrs.2020.104917_bib0340","doi-asserted-by":"crossref","first-page":"2643S","DOI":"10.3945\/jn.115.227280","article-title":"The importance of quality specifications in safety assessments of amino acids: the cases of l-tryptophan and l-citrulline","volume":"146","author":"Oketch-Rabah","year":"2016","journal-title":"J. Nutr."},{"issue":"6 Suppl 2","key":"10.1016\/j.phrs.2020.104917_bib0345","doi-asserted-by":"crossref","first-page":"1693S","DOI":"10.1093\/jn\/137.6.1693S","article-title":"Adverse gastrointestinal effects of arginine and related amino acids","volume":"137","author":"Grimble","year":"2007","journal-title":"J. Nutr."},{"key":"10.1016\/j.phrs.2020.104917_bib0350","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejphar.2014.01.070","article-title":"Arginine NO-dependent and NO-independent effects on hemodynamics","volume":"729","author":"Guridi","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"8716","key":"10.1016\/j.phrs.2020.104917_bib0355","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0140-6736(90)92196-O","article-title":"L-arginine-induced hypotension","volume":"336","author":"Nakaki","year":"1990","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0360","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0031-1278274","article-title":"The antihypertensive effect of arginine","volume":"17","author":"Vasdev","year":"2008","journal-title":"Int. J. Angiol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104917_bib0365","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF03348247","article-title":"The hypophosphatemic and hyperkalemic effect of arginine in man","volume":"3","author":"Massara","year":"1980","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.phrs.2020.104917_bib0370","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1186\/s40064-016-2224-3","article-title":"Tissue-specific regulation of potassium homeostasis by high doses of cationic amino acids","volume":"5","author":"Cremades","year":"2016","journal-title":"SpringerPlus"},{"issue":"2","key":"10.1016\/j.phrs.2020.104917_bib0375","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1017\/S0007114519002691","article-title":"The effects of oral arginine on its metabolic pathways in Sprague-Dawley rats","volume":"123","author":"Martin","year":"2020","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.phrs.2020.104917_bib0380","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fphys.2013.00381","article-title":"Functional muscle ischemia in Duchenne and Becker muscular dystrophy","volume":"4","author":"Thomas","year":"2013","journal-title":"Front. Physiol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104917_bib0385","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/0960327109104498","article-title":"Adverse effects associated with arginine alpha-ketoglutarate containing supplements","volume":"28","author":"Prosser","year":"2009","journal-title":"Hum. Exp. Toxicol."},{"issue":"6","key":"10.1016\/j.phrs.2020.104917_bib0390","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0261-5614(99)80017-X","article-title":"Is glutamine a\u2019 conditionally essential\u2019 amino acid in Duchenne muscular dystrophy?","volume":"18","author":"Hankard","year":"1999","journal-title":"Clin. Nutr. (Edinburgh, Scotland)"},{"issue":"11","key":"10.1016\/j.phrs.2020.104917_bib0395","doi-asserted-by":"crossref","DOI":"10.3390\/nu10111564","article-title":"Glutamine: metabolism and immune function, supplementation and clinical translation","volume":"10","author":"Cruzat","year":"2018","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0400","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ana.20523","article-title":"CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy","volume":"58","author":"Escolar","year":"2005","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104917_bib0405","doi-asserted-by":"crossref","first-page":"e5448","DOI":"10.1371\/journal.pone.0005448","article-title":"Lack of functional benefit with glutamine versus placebo in Duchenne muscular dystrophy: a randomized crossover trial","volume":"4","author":"Mok","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.phrs.2020.104917_bib0410","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/ajcn\/83.4.823","article-title":"Oral glutamine and amino acid supplementation inhibit whole-body protein degradation in children with Duchenne muscular dystrophy","volume":"83","author":"Mok","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.phrs.2020.104917_bib0415","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.clnu.2012.08.019","article-title":"Effect of glutamine on glucose metabolism in children with Duchenne muscular dystrophy","volume":"32","author":"Letellier","year":"2013","journal-title":"Clin. Nutr."},{"issue":"3","key":"10.1016\/j.phrs.2020.104917_bib0420","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/02652030601013729","article-title":"Survey of nutritional supplements for selected illegal anabolic steroids and ephedrine using LC-MS\/MS and GC-MS methods, respectively","volume":"24","author":"Martello","year":"2007","journal-title":"Food Addit. Contam."},{"key":"10.1016\/j.phrs.2020.104917_bib0425","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0031-6997(24)01490-X","article-title":"Clinical pharmacology of the dietary supplement creatine monohydrate","volume":"53","author":"Persky","year":"2001","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.phrs.2020.104917_bib0430","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0960-8966(01)00273-5","article-title":"Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice","volume":"12","author":"Passaquin","year":"2002","journal-title":"Neuromuscular disorders: NMD"},{"issue":"5","key":"10.1016\/j.phrs.2020.104917_bib0435","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/mus.20014","article-title":"Effect of creatine supplementation on skeletal muscle of mdx mice","volume":"29","author":"Louis","year":"2004","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0440","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/mus.20436","article-title":"Nutritional therapy improves function and complements corticosteroid intervention in mdx mice","volume":"33","author":"Payne","year":"2006","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0445","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1124\/jpet.102.041343","article-title":"Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1","volume":"304","author":"De Luca","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2020.104917_bib0450","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.mri.2010.03.008","article-title":"Effect of creatine monohydrate in improving cellular energetics and muscle strength in ambulatory Duchenne muscular dystrophy patients: a randomized, placebo-controlled 31P MRS study","volume":"28","author":"Banerjee","year":"2010","journal-title":"Magn. Reson. Imaging"},{"issue":"2","key":"10.1016\/j.phrs.2020.104917_bib0455","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/01616412.2000.11741051","article-title":"Oral creatine supplementation in Duchenne muscular dystrophy: a clinical and 31P magnetic resonance spectroscopy study","volume":"22","author":"Felber","year":"2000","journal-title":"Neurol. Res."},{"issue":"10","key":"10.1016\/j.phrs.2020.104917_bib0460","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1212\/01.WNL.0000125178.18862.9D","article-title":"Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy","volume":"62","author":"Tarnopolsky","year":"2004","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.phrs.2020.104917_bib0465","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1212\/WNL.54.9.1848","article-title":"Creatine monohydrate in muscular dystrophies: a double-blind, placebo-controlled clinical study","volume":"54","author":"Walter","year":"2000","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.phrs.2020.104917_bib0470","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/00042752-199810000-00007","article-title":"Potential side effects of oral creatine supplementation: a critical review","volume":"8","author":"Juhn","year":"1998","journal-title":"Clin. J. Sport. Med."},{"key":"10.1016\/j.phrs.2020.104917_bib0475","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fnut.2019.00124","article-title":"Variables influencing the effectiveness of creatine supplementation as a therapeutic intervention for Sarcopenia","volume":"6","author":"Candow","year":"2019","journal-title":"Front. Nutr."},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0480","first-page":"23","article-title":"The effects of the recommended dose of creatine monohydrate on kidney function","volume":"4","author":"Taner","year":"2011","journal-title":"NDT Plus"},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/J157v04n01_01","article-title":"Effects of creatine supplementation on renal function","volume":"4","author":"Yoshizumi","year":"2004","journal-title":"J. Herb. Pharmacother."},{"key":"10.1016\/j.phrs.2020.104917_bib0490","first-page":"457","article-title":"Drug-induced impairment of renal function","volume":"7","author":"Pazhayattil","year":"2014","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"issue":"5","key":"10.1016\/j.phrs.2020.104917_bib0495","doi-asserted-by":"crossref","first-page":"702","DOI":"10.2215\/CJN.11781017","article-title":"Hydroxychloroquine use and risk of CKD in patients with rheumatoid arthritis","volume":"13","author":"Wu","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2020.104917_bib0500","volume":"12","author":"Smith","year":"2020"},{"key":"10.1016\/j.phrs.2020.104917_bib0505","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12967-015-0610-1","article-title":"Taurine: the appeal of a safe amino acid for skeletal muscle disorders","volume":"13","author":"De Luca","year":"2015","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.phrs.2020.104917_bib0510","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/sj.bjp.0703907","article-title":"Alteration of excitation-contraction coupling mechanism in extensor digitorum longus muscle fibres of dystrophic mdx mouse and potential efficacy of taurine","volume":"132","author":"De Luca","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2020.104917_bib0515","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.phrs.2016.02.016","article-title":"Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of duchenne muscular dystrophy: a comparison with the gold standard, alpha-methyl prednisolone","volume":"106","author":"Capogrosso","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2020.104917_bib0520","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.trsl.2018.09.004","article-title":"A long-term treatment with taurine prevents cardiac dysfunction in mdx mice","volume":"204","author":"Mele","year":"2019","journal-title":"Transl. Res."},{"issue":"3","key":"10.1016\/j.phrs.2020.104917_bib0525","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2990.2010.01106.x","article-title":"Evaluation of potential synergistic action of a combined treatment with alpha-methyl-prednisolone and taurine on the mdx mouse model of Duchenne muscular dystrophy","volume":"37","author":"Cozzoli","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.phrs.2020.104917_bib0530","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/978-1-4614-6130-2_31","article-title":"Taurine regulation of blood pressure and vasoactivity","volume":"775","author":"El Idrissi","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0535","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0167-4889(02)00345-2","article-title":"Taurine modulates induction of cytochrome P450 3A4 mRNA by rifampicin in the HepG2 cell line","volume":"1593","author":"Matsuda","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.phrs.2020.104917_bib0540","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0895-7061(03)00915-4","article-title":"Effects of taurine and enalapril on kidney function of the hypertensive glucose-intolerant rat","volume":"16","author":"Mozaffari","year":"2003","journal-title":"Am. J. Hypertens."},{"issue":"3","key":"10.1016\/j.phrs.2020.104917_bib0545","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1542\/peds.2009-3592","article-title":"Health effects of energy drinks on children, adolescents, and young adults","volume":"127","author":"Seifert","year":"2011","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.phrs.2020.104917_bib0550","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.clnu.2009.10.001","article-title":"Green tea extract decreases muscle pathology and NF-kappaB immunostaining in regenerating muscle fibers of mdx mice","volume":"29","author":"Evans","year":"2010","journal-title":"Clin. Nutr."},{"issue":"6","key":"10.1016\/j.phrs.2020.104917_bib0555","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00418-012-0926-3","article-title":"Quantitative evaluation of the beneficial effects in the mdx mouse of epigallocatechin gallate, an antioxidant polyphenol from green tea","volume":"137","author":"Nakae","year":"2012","journal-title":"Histochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.phrs.2020.104917_bib0560","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/ajcn\/75.4.749","article-title":"Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species","volume":"75","author":"Buetler","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.phrs.2020.104917_bib0565","doi-asserted-by":"crossref","first-page":"C616","DOI":"10.1152\/ajpcell.00425.2005","article-title":"Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy","volume":"290","author":"Dorchies","year":"2006","journal-title":"Am. J. Physiol., Cell Physiol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104917_bib0570","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/19390211.2010.482041","article-title":"The dietary supplement protandim decreases plasma osteopontin and improves markers of oxidative stress in muscular dystrophy mdx mice","volume":"7","author":"Qureshi","year":"2010","journal-title":"J. Diet. Suppl."},{"issue":"10","key":"10.1016\/j.phrs.2020.104917_bib0575","doi-asserted-by":"crossref","DOI":"10.3390\/nu10101536","article-title":"Key findings and implications of a recent systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children","volume":"10","author":"Doepker","year":"2018","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.phrs.2020.104917_bib0580","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1051\/medsci\/20163205015","article-title":"[Mechanisms of caffeine-induced diuresis]","volume":"32","author":"Marx","year":"2016","journal-title":"Medecine sciences: M\/S"},{"issue":"11","key":"10.1016\/j.phrs.2020.104917_bib0585","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/ccr3.707","article-title":"Iron deficiency anemia due to excessive green tea drinking","volume":"4","author":"Fan","year":"2016","journal-title":"Clin. Case Rep."},{"key":"10.1016\/j.phrs.2020.104917_bib0590","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.biopha.2017.10.055","article-title":"Therapeutic dose of green tea extract provokes liver damage and exacerbates paracetamol-induced hepatotoxicity in rats through oxidative stress and caspase 3-dependent apoptosis","volume":"96","author":"El-Bakry","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.phrs.2020.104917_bib0595","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1158\/1940-6207.CAPR-17-0160","article-title":"Effect of green tea supplements on liver enzyme elevation: results from a randomized intervention study in the United States","volume":"10","author":"Yu","year":"2017","journal-title":"Cancer Prev. Res. Phila. (Phila)"},{"issue":"2","key":"10.1016\/j.phrs.2020.104917_bib0600","doi-asserted-by":"crossref","first-page":"188","DOI":"10.18433\/J3MS5C","article-title":"Inhibitory effects of eight green tea catechins on cytochrome P450 1A2, 2C9, 2D6, and 3A4 activities","volume":"19","author":"Satoh","year":"2016","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2020.104917_bib0605","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2133\/dmpk.DMPK-14-RG-015","article-title":"Effect of epigallocatechin gallate on drug transport mediated by the proton-coupled folate transporter","volume":"29","author":"Kissei","year":"2014","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"7","key":"10.1016\/j.phrs.2020.104917_bib0610","doi-asserted-by":"crossref","first-page":"15074","DOI":"10.3390\/ijms140715074","article-title":"Defective homocysteine metabolism: potential implications for skeletal muscle malfunction","volume":"14","author":"Veeranki","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"2S","key":"10.1016\/j.phrs.2020.104917_bib0615","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.jfda.2018.01.008","article-title":"Update of green tea interactions with cardiovascular drugs and putative mechanisms","volume":"26","author":"Werba","year":"2018","journal-title":"J. Food Drug Anal."},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0620","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40360-019-0332-8","article-title":"Effect of green tea on the gastrointestinal absorption of amoxicillin in rats","volume":"20","author":"Kiss","year":"2019","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"8","key":"10.1016\/j.phrs.2020.104917_bib0625","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1086\/507894","article-title":"Interactions between natural health products and antiretroviral drugs: pharmacokinetic and pharmacodynamic effects","volume":"43","author":"Lee","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"1\u20133","key":"10.1016\/j.phrs.2020.104917_bib0630","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0167-4889(01)00175-6","article-title":"Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols","volume":"1542","author":"Jodoin","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.phrs.2020.104917_bib0635","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1124\/dmd.31.4.452","article-title":"Glucuronides of tea catechins: enzymology of biosynthesis and biological activities","volume":"31","author":"Lu","year":"2003","journal-title":"Drug Metab. Dispos."},{"issue":"9","key":"10.1016\/j.phrs.2020.104917_bib0640","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1002\/jps.22568","article-title":"First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics","volume":"100","author":"Wu","year":"2011","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2020.104917_bib0645","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/cpdd.645","article-title":"Ataluren pharmacokinetics in healthy japanese and caucasian subjects","volume":"8","author":"Kong","year":"2019","journal-title":"Clin. Pharmacol. Drug Dev."},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0650","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.envpol.2005.04.025","article-title":"Scale and causes of lead contamination in Chinese tea","volume":"139","author":"Han","year":"2006","journal-title":"Environ. Pollut."},{"issue":"11","key":"10.1016\/j.phrs.2020.104917_bib0655","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1080\/19440049.2014.958575","article-title":"Residues and contaminants in tea and tea infusions: a review","volume":"31","author":"Abd El-Aty","year":"2014","journal-title":"Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess."},{"issue":"3","key":"10.1016\/j.phrs.2020.104917_bib0660","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10661-016-5157-y","article-title":"Monitoring of essential and heavy metals in green tea from different geographical origins","volume":"188","author":"Brzezicha-Cirocka","year":"2016","journal-title":"Environ. Monit. Assess."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2020.104917_bib0665","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jneuroim.2010.10.032","article-title":"Eicosapentaenoic acid decreases TNF-alpha and protects dystrophic muscles of mdx mice from degeneration","volume":"232","author":"Machado","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2020.104917_bib0670","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jneuroim.2013.09.007","article-title":"EPA protects against muscle damage in the mdx mouse model of Duchenne muscular dystrophy by promoting a shift from the M1 to M2 macrophage phenotype","volume":"264","author":"Carvalho","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104917_bib0675","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.clnu.2018.10.017","article-title":"Evidence of muscle loss delay and improvement of hyperinsulinemia and insulin resistance in Duchenne muscular dystrophy supplemented with omega-3 fatty acids: a randomized study","volume":"38","author":"Rodriguez-Cruz","year":"2019","journal-title":"Clin. Nutr."},{"issue":"4","key":"10.1016\/j.phrs.2020.104917_bib0680","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jada.2008.12.022","article-title":"A systemic review of the roles of n-3 fatty acids in health and disease","volume":"109","author":"Riediger","year":"2009","journal-title":"J. Am. Diet. Assoc."},{"key":"10.1016\/j.phrs.2020.104917_bib0685","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-319-16009-2_6","article-title":"Cytochrome p450 enzymes in the bioactivation of polyunsaturated Fatty acids and their role in cardiovascular disease","volume":"851","author":"Westphal","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0690","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1345\/aph.1D007","article-title":"Fish oil interaction with warfarin","volume":"38","author":"Buckley","year":"2004","journal-title":"Ann. Pharmacother."},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0695","doi-asserted-by":"crossref","first-page":"e13966","DOI":"10.14814\/phy2.13966","article-title":"Omega-3 multiple effects increasing glucocorticoid-induced muscle atrophy: autophagic, AMPK and UPS mechanisms","volume":"7","author":"Fappi","year":"2019","journal-title":"Physiol. Rep."},{"issue":"6A","key":"10.1016\/j.phrs.2020.104917_bib0700","doi-asserted-by":"crossref","first-page":"35C","DOI":"10.1016\/j.amjcard.2006.11.020","article-title":"Safety considerations with omega-3 fatty acid therapy","volume":"99","author":"Bays","year":"2007","journal-title":"Am. J. Cardiol."},{"issue":"9\u201312","key":"10.1016\/j.phrs.2020.104917_bib0705","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S0045-6535(98)00236-7","article-title":"Organochlorine residues in fish oil dietary supplements: comparison with industrial grade oils","volume":"37","author":"Jacobs","year":"1998","journal-title":"Chemosphere"},{"issue":"5","key":"10.1016\/j.phrs.2020.104917_bib0710","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1080\/10408398.2011.596292","article-title":"Bioavailability and potential uses of vegetarian sources of omega-3 fatty acids: a review of the literature","volume":"54","author":"Lane","year":"2014","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.phrs.2020.104917_bib0715","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/928385","article-title":"Optimizing bone health in Duchenne muscular dystrophy","volume":"2015","author":"Buckner","year":"2015","journal-title":"Int. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104917_bib0720","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3390\/healthcare3020219","article-title":"Vitamin d as an immunomodulator: risks with deficiencies and benefits of supplementation","volume":"3","author":"Goldsmith","year":"2015","journal-title":"Healthcare (Basel)"},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0725","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1056\/NEJM200107053450115","article-title":"Vitamin D intoxication associated with an over-the-counter supplement","volume":"345","author":"Koutkia","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.phrs.2020.104917_bib0730","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.bone.2009.06.012","article-title":"High-dose oral vitamin D3 supplementation in rheumatology patients with severe vitamin D3 deficiency","volume":"45","author":"von Restorff","year":"2009","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0735","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1194\/jlr.R031534","article-title":"Cytochrome P450-mediated metabolism of vitamin d","volume":"55","author":"Jones","year":"2014","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.phrs.2020.104917_bib0740","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.bbrc.2007.03.177","article-title":"Phenobarbital suppresses vitamin D3 25-hydroxylase expression: a potential new mechanism for drug-induced osteomalacia","volume":"357","author":"Hosseinpour","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2020.104917_bib0745","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/318595","article-title":"Vitamin d, essential minerals, and toxic elements: exploring interactions between nutrients and toxicants in clinical medicine","volume":"2015","author":"Schwalfenberg","year":"2015","journal-title":"TheScientificWorldJournal"},{"key":"10.1016\/j.phrs.2020.104917_bib0750","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9179270","article-title":"Resveratrol decreases oxidative stress by restoring mitophagy and improves the pathophysiology of dystrophin-deficient mdx mice","volume":"2018","author":"Sebori","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0755","doi-asserted-by":"crossref","first-page":"C66","DOI":"10.1152\/ajpcell.00357.2013","article-title":"Resveratrol induces expression of the slow, oxidative phenotype in mdx mouse muscle together with enhanced activity of the SIRT1-PGC-1alpha axis","volume":"307","author":"Ljubicic","year":"2014","journal-title":"Am. J. Physiol., Cell Physiol."},{"issue":"4","key":"10.1016\/j.phrs.2020.104917_bib0760","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1016-8478(23)17614-X","article-title":"Curcumin alleviates dystrophic muscle pathology in mdx mice","volume":"25","author":"Pan","year":"2008","journal-title":"Mol. Cells"},{"issue":"3","key":"10.1016\/j.phrs.2020.104917_bib0765","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/mus.20579","article-title":"Progressive nuclear factor-kappaB activation resistant to inhibition by contraction and curcumin in mdx mice","volume":"34","author":"Durham","year":"2006","journal-title":"Muscle Nerve"},{"issue":"1\u20133","key":"10.1016\/j.phrs.2020.104917_bib0770","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-4274(01)00418-0","article-title":"Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components","volume":"125","author":"Piver","year":"2001","journal-title":"Toxicol. Lett."},{"issue":"9","key":"10.1016\/j.phrs.2020.104917_bib0775","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1158\/1940-6207.CAPR-09-0155","article-title":"Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study","volume":"3","author":"Chow","year":"2010","journal-title":"Cancer Prev. Res. Phila. (Phila)"},{"issue":"3","key":"10.1016\/j.phrs.2020.104917_bib0780","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/03602532.2012.700715","article-title":"Drug interaction potential of resveratrol","volume":"44","author":"Detampel","year":"2012","journal-title":"Drug Metab. Rev."},{"issue":"4","key":"10.1016\/j.phrs.2020.104917_bib0785","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1517\/17425255.3.4.583","article-title":"The role of cytochrome P450 in antiretroviral drug interactions","volume":"3","author":"Walubo","year":"2007","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.phrs.2020.104917_bib0790","doi-asserted-by":"crossref","first-page":"21772","DOI":"10.1038\/srep21772","article-title":"Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition","volume":"6","author":"Park","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.phrs.2020.104917_bib0795","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cmet.2011.01.001","article-title":"Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle","volume":"13","author":"Shimizu","year":"2011","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.phrs.2020.104917_bib0800","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1083\/jcb.200903131","article-title":"Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy","volume":"187","author":"Risson","year":"2009","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0805","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biocel.2008.06.010","article-title":"Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases","volume":"41","author":"Aggarwal","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"20","key":"10.1016\/j.phrs.2020.104917_bib0810","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1158\/1078-0432.CCR-04-0744","article-title":"Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance","volume":"10","author":"Sharma","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.phrs.2020.104917_bib0815","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1158\/1940-6207.CAPR-10-0098","article-title":"Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia [published correction appears in Cancer Prev Res (Phila). 2012 Dec;5(12):1407. Dosage error in article text]","volume":"4","author":"Carroll","year":"2011","journal-title":"Cancer Prev. Res. Phila. (Phila)"},{"issue":"10","key":"10.1016\/j.phrs.2020.104917_bib0820","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1021\/np300392n","article-title":"Ultrasonic-assisted extraction of the botanical dietary supplement resveratrol and other constituents of Polygonum cuspidatum","volume":"75","author":"Chen","year":"2012","journal-title":"J. Nat. Prod."},{"issue":"2","key":"10.1016\/j.phrs.2020.104917_bib0825","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/foods5020036","article-title":"Evaluation of turmeric powder adulterated with metanil yellow using FT-Raman and FT-IR spectroscopy","volume":"5","author":"Dhakal","year":"2016","journal-title":"Foods."},{"key":"10.1016\/j.phrs.2020.104917_bib0830","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/730636","article-title":"Contaminated turmeric is a potential source of lead exposure for children in rural Bangladesh","volume":"2014","author":"Gleason","year":"2014","journal-title":"J. Environ. Public Health"},{"issue":"Pt A","key":"10.1016\/j.phrs.2020.104917_bib0835","doi-asserted-by":"crossref","first-page":"108722","DOI":"10.1016\/j.envres.2019.108722","article-title":"Turmeric means \u201cyellow\u201d in Bengali: lead chromate pigments added to turmeric threaten public health across Bangladesh","volume":"179","author":"Forsyth","year":"2019","journal-title":"Environ. Res."},{"issue":"5","key":"10.1016\/j.phrs.2020.104917_bib0840","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.nmd.2011.11.007","article-title":"N-Acetylcysteine treatment of dystrophic mdx mice results in protein thiol modifications and inhibition of exercise induced myofibre necrosis","volume":"22","author":"Terrill","year":"2012","journal-title":"Neuromuscular disorders: NMD"},{"issue":"3","key":"10.1016\/j.phrs.2020.104917_bib0845","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.clnu.2012.06.001","article-title":"Minatel E. N-acetylcysteine treatment reduces TNF-alpha levels and myonecrosis in diaphragm muscle of mdx mice","volume":"32","author":"de Senzi Moraes Pinto","year":"2013","journal-title":"Clin. Nutr."},{"issue":"7","key":"10.1016\/j.phrs.2020.104917_bib0850","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1113\/jphysiol.2007.148338","article-title":"N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice","volume":"586","author":"Whitehead","year":"2008","journal-title":"J. Physiol. (Lond.)"},{"issue":"11","key":"10.1016\/j.phrs.2020.104917_bib0855","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1113\/JP271418","article-title":"Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy","volume":"594","author":"Terrill","year":"2016","journal-title":"J. Physiol. (Lond.)"},{"issue":"3","key":"10.1016\/j.phrs.2020.104917_bib0860","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1179\/1351000214Y.0000000112","article-title":"Effect of N-acetylcysteine plus deferoxamine on oxidative stress and inflammation in dystrophic muscle cells","volume":"20","author":"Moraes","year":"2015","journal-title":"Redox Rep.: Commun. Free Radic. Res."},{"issue":"2","key":"10.1016\/j.phrs.2020.104917_bib0865","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/039463200702000215","article-title":"N-acetylcysteine synergizes with oseltamivir in protecting mice from lethal influenza infection","volume":"20","author":"Garozzo","year":"2007","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.phrs.2020.104917_bib0870","article-title":"Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus [published online ahead of print, 2020 Feb12]","author":"McCarty","year":"2020","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"7","key":"10.1016\/j.phrs.2020.104917_bib0875","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1183\/09031936.97.10071535","article-title":"Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment","volume":"10","author":"De Flora","year":"1997","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.phrs.2020.104917_bib0880","first-page":"245","article-title":"Pharmacokinetic and pharmacodynamic studies of N-acetylcysteine, a potential chemopreventive agent during a phase I trial","volume":"4","author":"Pendyala","year":"1995","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"6","key":"10.1016\/j.phrs.2020.104917_bib0885","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0891-5849(01)00640-2","article-title":"Supplementation with vitamin C and N-acetyl-cysteine increases oxidative stress in humans after an acute muscle injury induced by eccentric exercise","volume":"31","author":"Childs","year":"2001","journal-title":"Free Radic. Biol. Med."},{"issue":"23","key":"10.1016\/j.phrs.2020.104917_bib0890","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.1113\/JP274229","article-title":"Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy","volume":"595","author":"Pinniger","year":"2017","journal-title":"J. Physiol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104917_bib0895","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/mus.22047","article-title":"Cooperative International Neuromuscular Research Group I. CINRG pilot trial of coenzyme Q10 in steroid-treated duchenne muscular dystrophy","volume":"44","author":"Spurney","year":"2011","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0900","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0925-4439(95)00040-B","article-title":"Two successful double-blind trials with coenzyme Q10 (vitamin Q10) on muscular dystrophies and neurogenic atrophies","volume":"1271","author":"Folkers","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"issue":"13","key":"10.1016\/j.phrs.2020.104917_bib0905","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1073\/pnas.82.13.4513","article-title":"Biochemical rationale and the cardiac response of patients with muscle disease to therapy with coenzyme Q10","volume":"82","author":"Folkers","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.phrs.2020.104917_bib0910","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.19082\/3896","article-title":"Effectiveness of Coenzyme Q10 on echocardiographic parameters of patients with Duchenne muscular dystrophy","volume":"9","author":"Salehi","year":"2017","journal-title":"Electron. Physician"},{"key":"10.1016\/j.phrs.2020.104917_bib0915","unstructured":"Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD) - https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01027884."},{"issue":"9979","key":"10.1016\/j.phrs.2020.104917_bib0920","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/S0140-6736(15)60025-3","article-title":"Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial","volume":"385","author":"Buyse","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib0925","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40292-018-0247-2","article-title":"The effects of coenzyme Q10 supplementation on blood pressures among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials","volume":"25","author":"Tabrizi","year":"2018","journal-title":"High Blood Press. Cardiovasc. Prev."},{"issue":"2","key":"10.1016\/j.phrs.2020.104917_bib0930","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1600-079X.2011.00871.x","article-title":"Melatonin improves muscle function of the dystrophic mdx5Cv mouse, a model for Duchenne muscular dystrophy","volume":"51","author":"Hibaoui","year":"2011","journal-title":"J. Pineal Res."},{"issue":"3","key":"10.1016\/j.phrs.2020.104917_bib0935","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1600-079X.2010.00752.x","article-title":"Melatonin treatment normalizes plasma pro-inflammatory cytokines and nitrosative\/oxidative stress in patients suffering from Duchenne muscular dystrophy","volume":"48","author":"Chahbouni","year":"2010","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.phrs.2020.104917_bib0940","doi-asserted-by":"crossref","first-page":"117583","DOI":"10.1016\/j.lfs.2020.117583","article-title":"COVID-19: Melatonin as a potential adjuvant treatment [published online ahead of print, 2020 Mar 23]","author":"Zhang","year":"2020","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.phrs.2020.104917_bib0945","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-079X.2007.00499.x","article-title":"Oral melatonin reduces blood coagulation activity: a placebo-controlled study in healthy young men","volume":"44","author":"Wirtz","year":"2008","journal-title":"J. Pineal Res."},{"issue":"5","key":"10.1016\/j.phrs.2020.104917_bib0950","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1365-2125.2000.00195.x","article-title":"Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study","volume":"49","author":"Lusardi","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2020.104917_bib0955","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/jpc.12840","article-title":"Potential safety issues in the use of the hormone melatonin in paediatrics","volume":"51","author":"Kennaway","year":"2015","journal-title":"J. Paediatr. Child Health"},{"issue":"2","key":"10.1016\/j.phrs.2020.104917_bib0960","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5664\/jcsm.6462","article-title":"Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content","volume":"13","author":"Erland","year":"2017","journal-title":"J. Clin. Sleep Med."},{"issue":"2","key":"10.1016\/j.phrs.2020.104917_bib0965","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5664\/jcsm.6434","article-title":"Poor quality control of over-the-counter melatonin: what they say is often not what you get","volume":"13","author":"Grigg-Damberger","year":"2017","journal-title":"J. Clin. Sleep Med."},{"issue":"11","key":"10.1016\/j.phrs.2020.104917_bib0970","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0025-6196(11)63555-6","article-title":"Contaminants in commercial preparations of melatonin","volume":"72","author":"Williamson","year":"1997","journal-title":"Mayo Clin. Proc."},{"issue":"10","key":"10.1016\/j.phrs.2020.104917_bib0975","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.drudis.2018.05.030","article-title":"Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development","volume":"23","author":"Andersson","year":"2018","journal-title":"Drug Discov. Today"},{"issue":"14 Supplement","key":"10.1016\/j.phrs.2020.104917_bib0980","article-title":"In vitro pharmacokinetic evaluation of eteplirsen, SRP-4045, and SRP-4053; three phosphorodiamidate morpholino oligomers (PMO) for the treatment of patients with duchenne muscular dystrophy (DMD) (P5.061)","volume":"84","author":"Sazani","year":"2015","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.phrs.2020.104917_bib0985","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.15252\/emmm.201505636","article-title":"Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy [published correction appears in EMBO Mol Med. 2016 Dec 1;8(12):1470-1471]","volume":"7","author":"Cossu","year":"2015","journal-title":"EMBO Mol. Med."},{"issue":"140","key":"10.1016\/j.phrs.2020.104917_bib0990","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003541","article-title":"Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy","volume":"4","author":"Tedesco","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"18","key":"10.1016\/j.phrs.2020.104917_bib0995","doi-asserted-by":"crossref","first-page":"9700","DOI":"10.1074\/jbc.M115.704254","article-title":"Amino acid transport associated to cluster of differentiation 98 heavy chain (CD98hc) is at the cross-road of oxidative stress and amino acid availability","volume":"291","author":"de la Ballina","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2020.104917_bib1000","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3389\/fphys.2016.00599","article-title":"Endothelial progenitor cells physiology and metabolic plasticity in brain angiogenesis and blood-brain barrier modeling","volume":"7","author":"Malinovskaya","year":"2016","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2020.104917_bib1005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40104-016-0139-z","article-title":"Novel metabolic and physiological functions of branched chain amino acids: a review","volume":"8","author":"Zhang","year":"2017","journal-title":"J. Anim. Sci. Biotechnol."},{"issue":"10","key":"10.1016\/j.phrs.2020.104917_bib1010","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV micro-dystrophin gene therapy for duchenne muscular dystrophy","volume":"26","author":"Duan","year":"2018","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.phrs.2020.104917_bib1015","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.ymthe.2018.03.018","article-title":"Functional rescue of dystrophin deficiency in mice caused by frameshift mutations using Campylobacter jejuni Cas9","volume":"26","author":"Koo","year":"2018","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2020.104917_bib1020","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1152\/physiol.00012.2019","article-title":"CRISPR for neuromuscular disorders: gene editing and beyond","volume":"34","author":"Young","year":"2019","journal-title":"Physiology"},{"issue":"16","key":"10.1016\/j.phrs.2020.104917_bib1025","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1056\/NEJMsa1504267","article-title":"Emergency department visits for adverse events related to dietary supplements","volume":"373","author":"Geller","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib1030","doi-asserted-by":"crossref","first-page":"14659","DOI":"10.1038\/s41598-018-32613-w","article-title":"Supplementation with a selective amino acid formula ameliorates muscular dystrophy in mdx mice","volume":"8","author":"Banfi","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2020.104917_bib1035","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1203\/PDR.0b013e318163a259","article-title":"l-Glutamine administration reduces oxidized glutathione and MAP kinase signaling in dystrophic muscle of mdx mice","volume":"63","author":"Mok","year":"2008","journal-title":"Pediatr. Res."},{"issue":"3","key":"10.1016\/j.phrs.2020.104917_bib1040","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1152\/japplphysiol.00028.2008","article-title":"Endurance capacity in maturing mdx mice is markedly enhanced by combined voluntary wheel running and green tea extract","volume":"105","author":"Call","year":"2008","journal-title":"J. Appl. Physiol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104917_bib1045","article-title":"The effect of vitamin d supplementation on skeletal muscle in the mdx mouse model of duchenne muscular dystrophy","volume":"7","author":"Debruin","year":"2019","journal-title":"Sports (Basel, Switzerland)"},{"issue":"2","key":"10.1016\/j.phrs.2020.104917_bib1050","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00198-010-1275-5","article-title":"Low bone density and bone metabolism alterations in Duchenne muscular dystrophy: response to calcium and vitamin D treatment","volume":"22","author":"Bianchi","year":"2011","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib1055","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.clnu.2012.06.003","article-title":"Resveratrol decreases inflammation and increases utrophin gene expression in the mdx mouse model of Duchenne muscular dystrophy","volume":"32","author":"Gordon","year":"2013","journal-title":"Clin. Nutr."},{"issue":"1","key":"10.1016\/j.phrs.2020.104917_bib1060","doi-asserted-by":"crossref","first-page":"15555","DOI":"10.1038\/s41598-018-33930-w","article-title":"Resveratrol ameliorates mitophagy disturbance and improves cardiac pathophysiology of dystrophin-deficient mdx mice","volume":"8","author":"Kuno","year":"2018","journal-title":"Sci. Rep."},{"issue":"10\u201311","key":"10.1016\/j.phrs.2020.104917_bib1065","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.clinbiochem.2011.04.001","article-title":"Melatonin treatment counteracts the hyperoxidative status in erythrocytes of patients suffering from Duchenne muscular dystrophy","volume":"44","author":"Chahbouni","year":"2011","journal-title":"Clin. Biochem."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820312251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820312251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:16:56Z","timestamp":1760912216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661820312251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":213,"alternative-id":["S1043661820312251"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104917","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104917","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104917"}}